Berman McAleer’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Berman McAleer's VRTX Position: Q2 2026 in Review
Berman McAleer increased its Vertex Pharmaceuticals (VRTX) stake by 3.1% in Q2 2026, buying an estimated $7.53K and bringing the position to 574 shares worth $285K. The position accounts for 0.03% of the portfolio, ranked #133.
Berman McAleer first reported a position in VRTX in Q3 2025 and has held it in 4 quarters since. 1,743 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Berman McAleer held 574 shares of Vertex Pharmaceuticals worth $285K as of Q2 2026.
- Berman McAleer bought 17 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.53K.
- Vertex Pharmaceuticals made up 0.03% of Berman McAleer's portfolio in Q2 2026, its #133 holding.
- Berman McAleer first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- 1,743 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Berman McAleer's 13F filing for Q2 2026, filed 16 Jul 2026.